IL-1 Inhibition in Early TNBC (OZM-034)
ClinicalTrials.gov ID NCT06710197 Sponsor University Health Network, Toronto Information provided by University Health Network, Toronto (Responsible Party) Last Update Posted 2025-03-11 Study Overview Brief Summary This study will examine changes in the tumor microenvironment (TME) induced by 14 days of pre-operative IL-1-inhibiting therapy among patients with early breast cancer (including [READ MORE]